Author:
Ohtawa Masakatsu,Masuda Naoki,Akasaka Izumi,Nakashima Akinori,Ochiai Keiko,Moriyasu Matsuko
Subject
Pharmacology (medical),Pharmacology
Reference23 articles.
1. HMG-CoA reductase inhibitors: an exciting development in the treatment of hyperlipoproteinemia.;Kathawala;Med Res Rev,1991
2. . Effects of fluvastatin (XU 62-320): an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans.;Yuan;Atherosclerosis,1991
3. Metabolic fate of fluvastatin, an inhibitor of HMG-CoA reductase (1): absorption, distribution and excretion of [14C] fluvastatin after single administration in rats.;Masuda;Xenobiotic Metabolism and Disposition,1995
4. Berk PD Stremmel W Progress in liver disease 144
5. Uptake of HMG-CoA reductase inhibitors by rat hepatocytes: Relation to the multispecific anion transfer.;Sugiyama;Progress in Medicine,1991
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献